Epigenomics offers comprehensive Biomarker Services based on its leading DNA methylation technology portfolio. DNA methylation biomarkers support drug development at all stages - by helping to predict drug response and disease prognosis or to monitor treatment with a given drug.

Epigenomics can guide your way through all stages of biomarker development from discovery to final IVD assay.

Epigenomics' DNA Methylation Biomarker Services include: